A month without alcohol is easy to count. Recovery is a more demanding outcome. It concerns the disorder, the drinking pattern, daily functioning, and whether improvement lasts. For someone returning to a family business, a public role, or frequent travel, the relevant question is not only what happened during treatment. It is what happened afterward.
Key findings
442: participants analyzed from 501 enrolled in a prospective recovery-attempt study published online in September 2025.
Five analysis timepoints: baseline and 3, 6, 9, and 12 months; not everyone completed every follow-up.
Four predefined categories: remission with abstinence, remission with lower-risk drinking, remission with higher-risk drinking, and no remission.
102, 51, 70, and 219: the respective counts in the abstract. The Results text instead reports 221 without remission; this discrepancy remains unresolved.
These were predefined remission/drinking categories, not randomized treatment groups or a clinic’s 12-month success rates. Participants were not assigned to different drinking goals. [1]
Four categories, not four treatment arms
Source: Kelly, Belisario, and MacKillop. The counts describe highest attained category across follow-up, not final-visit percentages or sustained recovery. Hidden Markov models separately estimated transitions. [1]
A definition changes the success story
NIAAA’s research definition combines remission from alcohol use disorder with stopping heavy drinking, maintained over time. It also recognizes health, relationships, and quality of life as important dimensions. It does not require abstinence in every case, but neither does it define any reduction as complete recovery. [2]
That challenges two simplistic claims. One treats every nonabstinent outcome as failure. The other treats drinking less as sufficient evidence that the disorder has resolved. A defensible report states the drinking measure, disorder measure, and duration together.
The research definition is not a personal drinking allowance. Appropriate goals depend on clinical circumstances, medical conditions, previous patterns, and the ability to maintain change. An aggregate framework cannot establish that a particular level of drinking is safe for an individual.
| Outcome | What it measures | What else matters |
|---|---|---|
| Abstinence | No drinking in a defined period | Symptoms, functioning, and durability |
| Reduced drinking | A specified consumption reduction | Harms and disorder symptoms |
| Remission | Defined diagnostic criteria | Drinking pattern and duration |
| Sustained recovery | Clinical goals maintained over time | Support, recurrence, and daily life |
What the 2025 study adds
The study found greater remission stability among abstinent remitters than among the drinking-remission categories. Both abstinent and lower-risk remitters showed substantial psychosocial gains. Because people were not randomly assigned to the categories, the comparison does not establish the effect of instructing an individual to choose one goal rather than another. [1]
People who achieve different drinking patterns may differ before the comparison starts. Their histories, severity, and available support may affect both the pathway and the outcome. An observational study can identify useful patterns without removing those differences.
The study’s value is its repeated assessment. It examines change over time rather than treating recovery as a certificate issued once. A program’s outcome report should show the trajectory, not select the most favorable observation and let it stand for the whole year.
The first month is not the entire result
A structured treatment setting provides a particular environment for observing change. Responsibilities, social circumstances, and access to care may differ after discharge. A discharge assessment and a later follow-up therefore answer different questions, even when they use the same questionnaire.
For an executive or family-business owner, functioning should include valued roles without making economic output the definition of health. A gradual return can be compatible with progress. Immediately resuming every responsibility is not automatically the best outcome.
Follow-up should also document other care. Outpatient treatment, medication, peer support, or changes at home may contribute to later improvement. Assigning every subsequent gain to the initial residential program would overlook those contributions.
| Observation | Question | Reporting requirement |
|---|---|---|
| Baseline | What needs to change? | Severity, use, harms, functioning, and goals |
| 3 months | Has initial improvement occurred? | Consistent measures and number assessed |
| 6 months | Are gains being maintained? | Recurrence, continuing care, and missing results |
| 12 months | How durable is the result? | Observed outcomes and uncertainty |
Treatment is more than withdrawal management
NIAAA describes evidence-supported behavioral treatment, medication, and mutual-support approaches, used separately or in appropriate combinations. It distinguishes medically managed withdrawal from the ongoing treatment of alcohol use disorder. Completing withdrawal management does not finish the recovery process. [3]
Withdrawal can be medically dangerous. A person concerned about dependence or previous withdrawal should seek clinical advice before an abrupt change. A research article about outcomes is not an instruction to stop drinking without assessment. Seek emergency medical care for withdrawal symptoms such as seizures, confusion or hallucinations.
A family with substantial resources may be offered an extensive package. Ask what each component contributes, what evidence supports it, and how the plan changes if progress is insufficient. An exclusive setting does not make the underlying clinical questions less important.
Preferences about privacy can be addressed without silently excluding established treatment options. The program should explain the clinically appropriate choices and their place in the person’s plan. More components do not automatically produce more benefit, and a single treatment philosophy should not replace an individualized assessment.
The people missing from a success rate
A high proportion of follow-up respondents doing well may be encouraging. It remains essential to know how many eligible people responded. People who are harder to contact may differ from those who remain engaged, and their outcomes cannot simply be assumed to match the observed group.
A transparent report distinguishes admissions, completers, and respondents at each follow-up. Early departures should not disappear from the account, even when an analysis focuses on people completing a defined course. The report should explain what is known and what remains missing.
This does not require every service to run a randomized trial before offering care. It requires an honest description of observational results. A useful report can show progress while acknowledging that it does not establish superiority over another provider.
Why this matters for affluent families
Families may see progress through trust, communication, and the stability of daily life. Those concerns matter, but a relative’s impression is one perspective rather than a universal outcome measure. Family involvement should respect the patient’s consent and should not replace clinical assessment.
For an internationally mobile household, the care plan should clarify where follow-up occurs, who coordinates recommendations, and what records can be shared with permission. A family office or adviser may help with logistics without becoming the person’s clinician.
Financial authority should not be confused with authority over another adult’s treatment. The useful role is to support clear responsibilities and practical continuity. The cited study does not measure the effectiveness of family-office arrangements or quantify cross-border treatment failures.
What to ask when comparing programs
Start by asking how the program defines recovery. Does the report measure drinking, disorder symptoms, functioning, or all three? Ask whether outcomes are assessed at discharge or later, and whether the figures include people who left before completing the planned stay.
Then ask how the plan responds to different trajectories. Sustained abstinence, reduced harms, recurrence, and incomplete improvement require accurate description rather than a single marketing category. A thoughtful explanation should connect the measurement to clinical decisions, not merely demonstrate that a questionnaire was completed.
Finally, examine what happens after the initial package ends. Who receives follow-up results? Who discusses concerns with the patient? What continuing care was anticipated? For a person returning to demanding responsibilities, those practical arrangements may be more informative than a promise of transformation within a fixed stay.
What these numbers cannot tell us
The four abstract-reported category counts are not a clinic’s success rate or evidence that everyone should adopt the same drinking goal. The study is observational, and its predefined remission/drinking categories are not randomized groups. No THE BALANCE patient data or treatment-price comparison was analyzed.
The results also should not become a contest between abstinence and moderation slogans. They describe different patterns of remission, drinking, and functioning. Applying that evidence to an individual requires clinical judgment beyond a population definition.
The bottom line
A period without heavy drinking can be valuable. Understanding recovery also requires disorder symptoms, functioning, and duration. The strongest question for a family choosing care is what survives the return home and how that will be measured.
For journalists
Key finding: the 2025 study analyzed 442 participants with baseline and at least one follow-up, using predefined remission and drinking categories.
Important caveat: highest attained category is not a randomized treatment comparison, sustained recovery or a final-visit success percentage.
Suggested attribution: THE BALANCE analysis of published alcohol-recovery research and NIAAA definitions.
Methodology and sources
This narrative analysis presents the abstract’s category counts, flags the conflicting nonremission count in the Results text, and retains the analysis timepoints. It does not reanalyze participant data or estimate the effect of assigning a drinking goal. The proposed reporting table is a framework, not a presentation of proprietary clinical outcomes.


